PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain
Abstract
Authors
V. Moreno B. Martínez-Amores J. Barriuso L. Mezquita I. Ibáñez de Cáceres Á. Ayuso J.M. Peña R. Perona E. Grande C. Belda-Iniesta